The 36-month beta value for NCNA is also noteworthy at 1.05. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 3 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for NCNA is 1.98M, and at present, short sellers hold a 3.15% of that float. The average trading volume of NCNA on September 16, 2024 was 135.56K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NCNA) stock’s latest price update
The stock price of NuCana plc ADR (NASDAQ: NCNA) has jumped by 137.99 compared to previous close of 2.54. Despite this, the company has seen a gain of 123.06% in its stock price over the last five trading days. globenewswire.com reported 2024-09-14 that Combination of NUC-7738 plus Pembrolizumab Resulted in Prolonged Progression Free Survival, a Compelling Disease Control Rate including Partial Responses, and a Favorable Safety Profile Combination of NUC-7738 plus Pembrolizumab Resulted in Prolonged Progression Free Survival, a Compelling Disease Control Rate including Partial Responses, and a Favorable Safety Profile
NCNA’s Market Performance
NCNA’s stock has risen by 123.06% in the past week, with a monthly rise of 83.74% and a quarterly rise of 101.50%. The volatility ratio for the week is 15.54% while the volatility levels for the last 30 days are 26.70% for NuCana plc ADR The simple moving average for the last 20 days is 15.79% for NCNA’s stock, with a simple moving average of 5.88% for the last 200 days.
Analysts’ Opinion of NCNA
Truist gave a rating of “Buy” to NCNA, setting the target price at $22 in the report published on October 22nd of the previous year.
NCNA Trading at 48.31% from the 50-Day Moving Average
After a stumble in the market that brought NCNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.16% of loss for the given period.
Volatility was left at 26.70%, however, over the last 30 days, the volatility rate increased by 15.54%, as shares surge +79.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +124.92% upper at present.
During the last 5 trading sessions, NCNA rose by +132.10%, which changed the moving average for the period of 200-days by -46.47% in comparison to the 20-day moving average, which settled at $5.36. In addition, NuCana plc ADR saw -18.26% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NCNA
The total capital return value is set at -8.47. Equity return is now at value -179.05, with -91.15 for asset returns.
Based on NuCana plc ADR (NCNA), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at -61.61.
Currently, EBITDA for the company is -28.89 million with net debt to EBITDA at 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.08.
Conclusion
In summary, NuCana plc ADR (NCNA) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
